Tenax Therapeutics Announces $8.0 Million Registered Direct and PIPE Offerings Priced At-the-Market Under Nasdaq Rules

Tenax Therapeutics, Inc. (Nasdaq: TENX) („Tenax” or the „Company”), a specialty pharmaceutical …

Tenax Therapeutics, Inc. (Nasdaq: TENX) ("Tenax” or the "Company”), a specialty pharmaceutical ...